PREVENTING OVERDOSES

MD-Bio provides rapid drug test strips that help Harm Reduction communities detect substances like fentanyl, xylazine, benzodiazepines, medetomidine, and nitazenes before use.

This gives individuals and organizations the power to prevent overdoses.

DRUG TEST KITS FOR EVERY SCENARIO

The Drug Supply has changed

Substances are increasingly contaminated with unexpected compounds like fentanyl and xylazine. Individuals often do not know what is present before use.

MD-Bio’s harm reduction test kits provide a simple way to detect dangerous substances and prevent overdose risk.

72,108

drug overdose deaths in the U.S. in 2025

210

people die each day from opioid-related overdoses

92.3%

of drug overdose deaths in the U.S. were unintentional

13,026

deaths in 2023 involving prescription opioids

131.8M

opioid prescriptions were dispensed in the U.S.

~80,000

deaths involving synthetic opioids (e.g. fentanyl) in 2023

Source: Centers for Disease Control and Prevention (CDC) & National Institute on Drug Abuse (NIDA)

Prevention is the First Line of Defense

Prevention (Before Use)

Reaction (After Overdose)

Prevention focuses on reducing overdose risk before consumption

Reaction occurs after an overdose has already occurred

Drug test kits helps prevent overdoses from a wide range of substances

Naloxone can only respond to overdoses from opioids

Drug test kits are proactive, affordable, and educational

Overdose response is risky, high cost, and time-sensitive

Test What You Take

Testing helps identify unexpected substances and reduce uncertainty before exposure occurs.

Know What You're Taking

Substances can vary widely in strength and composition. Information reduces uncertainty and risk.

Avoid Mixing Substances

Combining substances increases unpredictability and significantly raises overdose risk.

Be Prepared

Having the right information and tools on hand supports safer decision-making in real time.